- Home
- FMC vs BHC Comparison
FMC vs BHC Comparison
Compare FMC & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FMC | BHC |
|---|---|---|
| Founded | 1910 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 1994 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FMC | BHC |
|---|---|---|
| Price | $11.85 | $5.06 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 13 | 3 |
| Target Price | ★ $18.50 | $8.00 |
| AVG Volume (30 Days) | ★ 2.7M | 1.8M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.18% | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | $4,727,800,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $7.89 | $4.61 |
| Revenue Next Year | $4.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.72 | $4.93 |
| 52 Week High | $44.68 | $8.69 |
Technical Indicators
Market Signals| Indicator | FMC | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 41.70 | 40.42 |
| Support Level | N/A | $4.93 |
| Resistance Level | $14.31 | $6.31 |
| Average True Range (ATR) | 0.65 | 0.21 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 36.44 | 17.20 |
Price Performance
Historical ComparisonAbout FMC FMC Corporation
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.